ASC-J9 shows a lot of potential. The company that is researching the potential of this compound is currently working with the National Institute of Health (NIH) to perform additional testing on mouse models to help determine the potential and safety of this drug. Once the safety and effectiveness of this compound is confirmed, the NIH will consider sponsoring a clinical trial. This trial could within the next two years if everything goes well.Please feel free to comment. By taking a moment to share your thoughts you add much to these articles. The articles then become more than just something I said or believe. In addition, by adding a comment, you might just be helping the next reader by sharing your opinion, experience, or a helpful tip. You can comment by clicking on "comments" below or by sending me an email. I look forward to hearing from you.
Even though there doesn't seem to be any current news on how this trial is progressing, I was wondering if you have heard anything...? It seems like nothing has been really said since 2010 or 2011. Any news?
ReplyDeleteThe drug was shipped to NIH for testing on small mammals and is being tested as I write. If it continues to show positive results, it could be available for a human trial in late 2013 or 14.
ReplyDelete